Cargando…
Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up
Prostate cancer (PCa) is the most prevalent among men, and psychological symptoms may affect many patients. This study aims to describe the prevalence of probable anxiety and depression before PCa treatments and after one year and to identify sociodemographic and clinical factors associated with the...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368515/ https://www.ncbi.nlm.nih.gov/pubmed/35897487 http://dx.doi.org/10.3390/ijerph19159122 |
_version_ | 1784766158962950144 |
---|---|
author | Duarte, Vítor Araújo, Natália Lopes, Catarina Costa, Adriana Ferreira, Augusto Carneiro, Filipa Oliveira, Jorge Braga, Isaac Morais, Samantha Pacheco-Figueiredo, Luís Ruano, Luis Tedim Cruz, Vítor Pereira, Susana Lunet, Nuno |
author_facet | Duarte, Vítor Araújo, Natália Lopes, Catarina Costa, Adriana Ferreira, Augusto Carneiro, Filipa Oliveira, Jorge Braga, Isaac Morais, Samantha Pacheco-Figueiredo, Luís Ruano, Luis Tedim Cruz, Vítor Pereira, Susana Lunet, Nuno |
author_sort | Duarte, Vítor |
collection | PubMed |
description | Prostate cancer (PCa) is the most prevalent among men, and psychological symptoms may affect many patients. This study aims to describe the prevalence of probable anxiety and depression before PCa treatments and after one year and to identify sociodemographic and clinical factors associated with these outcomes. Between February 2018 and March 2020, 292 patients recently diagnosed with PCa were recruited at the Instituto Português de Oncologia—Porto. The Hospital Anxiety and Depression Scale (HADS) was used to define probable anxiety and depression (cutoff = 11). The prevalence of probable anxiety remained stable from baseline to one year (7.8% vs. 8.5%, p = 0.866) while there was an increase in probable depression (3.1% vs. 6.8%, p = 0.012). After one year, probable depression persisted in 55.6% of patients with probable depression at baseline and 47.8% of those with probable anxiety at the first assessment had normal anxiety scores. At baseline, anxiety was more frequent among dwellers in rural areas (adjusted odds ratio—aOR, 95%CI: 2.80, 0.91–8.58) and less frequent in patients with body mass index 25–29.9 kg/m(2) (aOR, 95%CI: 0.33, 0.12–0.91) compared to 18.5–24.9 Kg/m(2), while those living alone had higher odds of depression (aOR, 95%CI: 6.35, 1.43–28.30). The frequency of anxiety and depression fluctuated during the course of treatment. Monitoring these symptoms would identify the most affected patients, contributing for a better use of mental health services. |
format | Online Article Text |
id | pubmed-9368515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93685152022-08-12 Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up Duarte, Vítor Araújo, Natália Lopes, Catarina Costa, Adriana Ferreira, Augusto Carneiro, Filipa Oliveira, Jorge Braga, Isaac Morais, Samantha Pacheco-Figueiredo, Luís Ruano, Luis Tedim Cruz, Vítor Pereira, Susana Lunet, Nuno Int J Environ Res Public Health Article Prostate cancer (PCa) is the most prevalent among men, and psychological symptoms may affect many patients. This study aims to describe the prevalence of probable anxiety and depression before PCa treatments and after one year and to identify sociodemographic and clinical factors associated with these outcomes. Between February 2018 and March 2020, 292 patients recently diagnosed with PCa were recruited at the Instituto Português de Oncologia—Porto. The Hospital Anxiety and Depression Scale (HADS) was used to define probable anxiety and depression (cutoff = 11). The prevalence of probable anxiety remained stable from baseline to one year (7.8% vs. 8.5%, p = 0.866) while there was an increase in probable depression (3.1% vs. 6.8%, p = 0.012). After one year, probable depression persisted in 55.6% of patients with probable depression at baseline and 47.8% of those with probable anxiety at the first assessment had normal anxiety scores. At baseline, anxiety was more frequent among dwellers in rural areas (adjusted odds ratio—aOR, 95%CI: 2.80, 0.91–8.58) and less frequent in patients with body mass index 25–29.9 kg/m(2) (aOR, 95%CI: 0.33, 0.12–0.91) compared to 18.5–24.9 Kg/m(2), while those living alone had higher odds of depression (aOR, 95%CI: 6.35, 1.43–28.30). The frequency of anxiety and depression fluctuated during the course of treatment. Monitoring these symptoms would identify the most affected patients, contributing for a better use of mental health services. MDPI 2022-07-26 /pmc/articles/PMC9368515/ /pubmed/35897487 http://dx.doi.org/10.3390/ijerph19159122 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Duarte, Vítor Araújo, Natália Lopes, Catarina Costa, Adriana Ferreira, Augusto Carneiro, Filipa Oliveira, Jorge Braga, Isaac Morais, Samantha Pacheco-Figueiredo, Luís Ruano, Luis Tedim Cruz, Vítor Pereira, Susana Lunet, Nuno Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up |
title | Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up |
title_full | Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up |
title_fullStr | Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up |
title_full_unstemmed | Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up |
title_short | Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up |
title_sort | anxiety and depression in patients with prostate cancer, at cancer diagnosis and after a one-year follow-up |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368515/ https://www.ncbi.nlm.nih.gov/pubmed/35897487 http://dx.doi.org/10.3390/ijerph19159122 |
work_keys_str_mv | AT duartevitor anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT araujonatalia anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT lopescatarina anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT costaadriana anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT ferreiraaugusto anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT carneirofilipa anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT oliveirajorge anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT bragaisaac anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT moraissamantha anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT pachecofigueiredoluis anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT ruanoluis anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT tedimcruzvitor anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT pereirasusana anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup AT lunetnuno anxietyanddepressioninpatientswithprostatecanceratcancerdiagnosisandafteraoneyearfollowup |